How do you pay?

How to pay the least

Cash price

$8,110+ for 30 capsules

Pharmacies pay about this for Ingrezza; you’d pay more.

  1. Ask your pharmacy for Ingrezza’s cash price, and one or two other pharmacies too.
  2. Ingrezza’s savings card works only with insurance from a job or one you bought.

No generic is sold yet.

Compare every option

Question
Brand nameIngrezza
Authorized genericvalbenazine
Regular genericvalbenazine
What you’d pay
At least$8,110for 30 capsules; pharmacies pay this
Not soldThere isn’t one
Not soldNone sold yet
Same as Ingrezza?
The original
–
–

Brand nameThe maker’s card

INGREZZA Savings Program (Neurocrine Access Support)

Savings card from Neurocrine Biosciences

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a fill

Sign up on ingrezza.com 

Or call 1-844-647-3992.

In the maker’s words

“Commercially insured patients may pay as little as $0.”

From the maker’s offer on ingrezza.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Ingrezza itself, from the same company, sold without the brand name, and usually for less. For now Ingrezza is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

INGREZZA and INGREZZA SPRINKLE are vesicular monoamine transporter 2 (VMAT2) inhibitors indicated for the treatment of adults with: - tardive dyskinesia. - chorea associated with Huntington’s disease.

Source: the FDA label for Ingrezza (Neurocrine Biosciences, Inc.), April 17, 2026. Full label on DailyMed 

Good to know